|
|
||||||||
Journal of Lipid Research, Vol 34, 201-210, Copyright © 1993 by Lipid Research, Inc.
ARTICLES |
MG Traber, RJ Sokol, A Kohlschutter, T Yokota, DP Muller, R Dufour and HJ Kayden
Department of Medicine, New York University School of Medicine, NY 10016.
We assessed whether patients with familial isolated vitamin E deficiency could discriminate between natural (RRR-) and synthetic (SRR- ) stereoisomers of alpha-tocopherol labeled with six (d6) or three (d3) deuterium atoms, respectively. After oral administration of 20 mg of each of the stereoisomers, patients (seven) and controls (seven) had similar concentrations of both in chylomicrons, similar initial increases of both, and similar rates of decrease of d3-SRR-alpha- tocopherol in plasma. Patients and controls differed in their abilities to maintain plasma d6-RRR-alpha-tocopherol concentrations. Controls maintained plasma d6-RRR-alpha-tocopherol concentrations by preferentially secreting it in very low density lipoprotein (VLDL). Three of seven patients did not discriminate between the two stereoisomers and their plasma and lipoprotein d6-RRR-alpha-tocopherol concentrations declined rapidly. The remaining patients were intermediate between non-discriminators and controls in their ability to discriminate and maintain plasma d6-RRR-alpha-tocopherol concentrations. The degree of discrimination between the two stereoisomers in the patients was correlated with the age of onset of the neurologic disability (r2 = 0.64, P < 0.03). Estimates based on the rate of decrease of plasma d6-RRR-alpha-tocopherol in non- discriminators suggest that the entire plasma alpha-tocopherol pool of normal subjects is replaced daily. We suggest 1) that a hepatic alpha- tocopherol binding protein, which preferentially incorporates RRR-alpha- tocopherol into VLDL, is required to maintain plasma RRR-alpha- tocopherol concentrations; 2) that non-discriminators are lacking this protein, or have a marked defect in the RRR-alpha-tocopherol binding region of the protein; and 3) that patients who discriminate, but have difficulty maintaining plasma RRR-alpha-tocopherol concentrations, have a less severe defect, or perhaps a defect in the transfer function of the protein.
This article has been cited by other articles:
![]() |
M. G Traber Heart disease and single-vitamin supplementation Am. J. Clinical Nutrition, January 1, 2007; 85(1): 293S - 299S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. TRABER, G. W. BURTON, and R. L. HAMILTON Vitamin E Trafficking Ann. N.Y. Acad. Sci., December 1, 2004; 1031(1): 1 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L Stone, I. LeClair, T. Ponder, G. Baggs, and B. B. Reis Infants discriminate between natural and synthetic vitamin E Am. J. Clinical Nutrition, April 1, 2003; 77(4): 899 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kolleck, P. Sinha, and B. Rustow Vitamin E as an Antioxidant of the Lung: Mechanisms of Vitamin E Delivery to Alveolar Type II Cells Am. J. Respir. Crit. Care Med., December 15, 2002; 166(12): S62 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W Leonard, Y. Terasawa, R. V Farese Jr, and M. G Traber Incorporation of deuterated RRR- or all-rac-{alpha}-tocopherol in plasma and tissues of {alpha}-tocopherol transfer protein-null mice Am. J. Clinical Nutrition, March 1, 2002; 75(3): 555 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Jiang, S. Christen, M. K Shigenaga, and B. N Ames {gamma}-Tocopherol, the major form of vitamin E in the US diet, deserves more attention Am. J. Clinical Nutrition, December 1, 2001; 74(6): 714 - 722. [Abstract] [Full Text] |
||||
![]() |
H.-M. Shaw and C.-j. Huang Secretion of {{alpha}}-Tocopherol in VLDL Is Decreased by Dietary Protein Insufficiency in Young Growing Rats J. Nutr., December 1, 2000; 130(12): 3050 - 3054. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schuelke, A. Elsner, B. Finckh, A. Kohlschütter, C. Hübner, and R. Brigelius-Flohé Urinary {alpha}-tocopherol metabolites in {alpha}-tocopherol transfer protein-deficient patients J. Lipid Res., October 1, 2000; 41(10): 1543 - 1551. [Abstract] [Full Text] |
||||
![]() |
Y. Terasawa, S. J. Cases, J. S. Wong, H. Jamil, S. Jothi, M. G. Traber, L. Packer, D. A. Gordon, R. L. Hamilton, and R. V. Farese , Jr. Apolipoprotein B-related gene expression and ultrastructural characteristics of lipoprotein secretion in mouse yolk sac during embryonic development J. Lipid Res., November 1, 1999; 40(11): 1967 - 1977. [Abstract] [Full Text] |
||||
![]() |
H.-M. Shaw and C.-j. Huang Liver alpha -Tocopherol Transfer Protein and Its mRNA Are Differentially Altered by Dietary Vitamin E Deficiency and Protein Insufficiency in Rats J. Nutr., December 1, 1998; 128(12): 2348 - 2354. [Abstract] [Full Text] |
||||
![]() |
J. Neuzil, P. K. Witting, and R. Stocker alpha -Tocopheryl hydroquinone is an efficient multifunctional inhibitor of radical-initiated oxidation of low density lipoprotein lipids PNAS, July 22, 1997; 94(15): 7885 - 7890. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Thomas, J. Neuzil, and R. Stocker Cosupplementation With Coenzyme Q Prevents the Prooxidant Effect of {alpha}-Tocopherol and Increases the Resistance of LDL to Transition Metal–Dependent Oxidation Initiation Arterioscler. Thromb. Vasc. Biol., May 1, 1996; 16(5): 687 - 696. [Abstract] [Full Text] |
||||
![]() |
T. Gotoda, M. Arita, H. Arai, K. Inoue, T. Yokota, Y. Fukuo, Y. Yazaki, and N. Yamada Adult-Onset Spinocerebellar Dysfunction Caused by a Mutation in the Gene for the {alpha}-Tocopherol-Transfer Protein N. Engl. J. Med., November 16, 1995; 333(20): 1313 - 1319. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |